advertisement

---

Canepa E 1

Showing records 1 to 1 | Display all abstracts from Canepa E

108598 FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness
Canepa E; Parodi-Rullan R; Vazquez-Torres R; Gamallo-Lana B; Guzman-Hernandez R; Lemon NL; Angiulli F; Debure L; Ilies MA; Østergaard L; Wisniewski T; Gutiérrez-Jiménez E; Mar AC; Fossati S
Alzheimer's & dementia : the journal of the Alzheimer's Association 2023; 19: 5048-5073

---